Is the stepping‐down approach a better option than multiple daily injections in obese patients with poorly controlled Type 2 diabetes on advanced insulin therapy?-Reference-Cited by-同舟云学术

Is the stepping‐down approach a better option than multiple daily injections in obese patients with poorly controlled Type 2 diabetes on advanced insulin therapy?

Published:2020-12-20 Issue:2 Volume:4 Page:
ISSN:2398-9238
Container-title:Endocrinology, Diabetes & Metabolism
language:en
Short-container-title:Endocrino Diabet & Metabol

Author:

Naing Soe¹^ORCID,Ramesh Geeta²,Garcha Jasmine²,Poliyedath Anupama³,Khandelwal Stutee⁴,Mills Paul K.⁴

Affiliation:

1. Division of Endocrinology University of California San Francisco, Fresno Medical Education Program Fresno CA USA

2. Department of Family & Community Medicine University of California San Francisco, Fresno Medical Education Program Fresno CA USA

3. Department of Internal Medicine St Agnes Internal Medicine Residency Program Fresno CA USA

4. Department of Internal Medicine University of California San Francisco, Fresno Medical Education Program Fresno CA USA

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/edm2.204

Reference15 articles.

1. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

2. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

3. The potent synergistic effects of the combination of liraglutide and canagliflozin on glycemic control and weight loss

4. Diabetes Medication Satisfaction Tool

5. Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification;Diabetes Therapy;2024-06-27

2. De-escalating treatment indications for patients who achieve metabolic goals;Diabetes Research and Clinical Practice;2024-02

3. Simplification of Complex Insulin Regimens with IdegLira in People with Type 2 Diabetes: Literature Review and Clinical Recommendations;Diabetes Therapy;2023-09-22

4. Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes;Journal of Clinical Medicine;2023-06-08

5. Injektionstherapie (GLP1-Rezeptor Agonisten und Insulin) bei Typ 2 Diabetes mellitus (Update 2023);Wiener klinische Wochenschrift;2023-01